GlassScriptPhysician profile
Dwight D Kett
NPI 1205940988
$1,035.58
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $31.94 · 2021: $68.63 · 2022: $493 · 2023: $285 · 2024: $157.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $442.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $442.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $141.88 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $137.22 | 2022-2024 | |
| Hologic Sales and Service, LLC | $128.25 | 2022-2024 | Acessa Provu System, Coolseal Generator |
| Myovant Sciences INC. | $119.76 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $66.30 | 2022-2023 | |
| Scynexis, INC. | $63.68 | 2021-2022 | |
| Therapeuticsmd, INC. | $55.18 | 2022 | |
| Mylan Pharmaceuticals INC. | $50.57 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $47.01 | 2023 | Myfembree |
| Abbvie INC. | $46.04 | 2023 | |
| Coopersurgical, INC. | $36.33 | 2022-2024 | Paragard T 380a |
| Roche Diagnostics Corporation | $31.94 | 2019 | |
| Astellas Pharma US INC | $24.84 | 2024 | Veozah |
| Pfizer INC. | $24.54 | 2024 | |
| Convatec INC. | $22.89 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $21.16 | 2024 | |
| Exeltis, USA INC. | $17.99 | 2024 | Slynd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dwight Kett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.